Wealthfront Advisers LLC Grows Stock Holdings in Mettler-Toledo International, Inc. $MTD

Wealthfront Advisers LLC boosted its position in Mettler-Toledo International, Inc. (NYSE:MTD) by 38.5% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 1,115 shares of the medical instruments supplier’s stock after acquiring an additional 310 shares during the period. Wealthfront Advisers LLC’s holdings in Mettler-Toledo International were worth $1,310,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of MTD. Vanguard Group Inc. grew its stake in shares of Mettler-Toledo International by 1.2% during the 1st quarter. Vanguard Group Inc. now owns 2,543,365 shares of the medical instruments supplier’s stock valued at $3,003,485,000 after buying an additional 30,535 shares during the period. Alliancebernstein L.P. grew its stake in shares of Mettler-Toledo International by 21.6% during the 1st quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock valued at $837,653,000 after buying an additional 126,147 shares during the period. Price T Rowe Associates Inc. MD grew its stake in shares of Mettler-Toledo International by 5.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 481,011 shares of the medical instruments supplier’s stock valued at $568,032,000 after buying an additional 25,272 shares during the period. T. Rowe Price Investment Management Inc. grew its stake in shares of Mettler-Toledo International by 11.9% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 406,189 shares of the medical instruments supplier’s stock valued at $479,673,000 after buying an additional 43,082 shares during the period. Finally, PineStone Asset Management Inc. grew its stake in shares of Mettler-Toledo International by 41.9% during the 2nd quarter. PineStone Asset Management Inc. now owns 334,349 shares of the medical instruments supplier’s stock valued at $392,766,000 after buying an additional 98,737 shares during the period. 95.07% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on MTD. Bank of America boosted their price objective on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research note on Monday, September 22nd. JPMorgan Chase & Co. boosted their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a research note on Thursday, October 9th. Citigroup boosted their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a research note on Thursday, August 21st. Evercore ISI upped their price target on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 7th. Finally, Barclays upped their price target on shares of Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the stock an “overweight” rating in a research report on Thursday, October 2nd. Five analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $1,336.50.

Mettler-Toledo International Trading Down 1.5%

Shares of Mettler-Toledo International stock opened at $1,373.40 on Friday. The company has a fifty day moving average price of $1,304.55 and a 200 day moving average price of $1,218.30. Mettler-Toledo International, Inc. has a twelve month low of $946.69 and a twelve month high of $1,454.68. The stock has a market cap of $28.29 billion, a price-to-earnings ratio of 34.78, a price-to-earnings-growth ratio of 4.19 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, beating analysts’ consensus estimates of $9.58 by $0.51. The company had revenue of $983.22 million during the quarter, compared to analysts’ expectations of $957.41 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The firm’s revenue for the quarter was up 3.9% on a year-over-year basis. During the same period in the prior year, the company posted $9.65 EPS. Analysts forecast that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, CFO Shawn Vadala sold 300 shares of the company’s stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $1,254.09, for a total value of $376,227.00. Following the completion of the transaction, the chief financial officer directly owned 5,095 shares of the company’s stock, valued at $6,389,588.55. This represents a 5.56% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Gerry Keller sold 165 shares of the company’s stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the completion of the transaction, the insider directly owned 94 shares of the company’s stock, valued at approximately $123,012.16. The trade was a 63.71% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 1,827 shares of company stock valued at $2,371,208 in the last ninety days. Insiders own 1.94% of the company’s stock.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.